• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Organogenesis Inc.

The medtech companies potentially affected by Silicon Valley Bank’s closure

March 13, 2023 By Sean Whooley

U.S. banking regulators’ latest moves may provide some reassurance for medtech and other companies exposed to Silicon Valley Bank‘s closure. The California Department of Financial Protection and Innovation shuttered SVB on March 10 to stave off what was turning into an old-fashioned bank run. Silicon Valley Bank has been a huge name in the tech […]

Filed Under: Business/Financial News, Featured, Funding Roundup, News Well, Wall Street Beat Tagged With: atricure, Humacyte, iRhythm Technologies, Lensar, Organogenesis Inc., Silicon Valley Bank, startups, treacemedical, Vericel Corp

Organogenesis beats The Street in Q2

August 10, 2021 By Danielle Kirsh

Organogenesis (NSDQ:ORGO) posted second-quarter results this week that beat the overall consensus on Wall Street. The Canton, Mass.–based regenerative medicine company reported profits of $20.7 million, or 15¢ per share, on sales of $123.2 million for the three months ended June 30 for a sales growth of 78.65% compared with Q2 2020. Earnings per share were […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Organogenesis Inc.

Organogenesis names new chief financial officer

February 17, 2021 By Danielle Kirsh

Organogenesis this week said it appointed David Francisco as the company’s chief financial officer, effective Feb. 15. Francisco replaces Henry Hagopian, who will move on to become the company’s senior VP of finance and treasurer. “I am pleased to welcome Dave to the Organogenesis executive leadership team,” president and CEO Gary Gillheeney said in a […]

Filed Under: Business/Financial News Tagged With: Organogenesis Inc.

Organogenesis up 10% on Street-beating Q2 results

August 11, 2020 By Danielle Kirsh

Organogenesis (NSDQ:ORGO) posted second-quarter results this week that beat the consensus on Wall Street. The Canton, Mass.-based company reported losses of $5.2 million, or -5¢ per share, on sales of $68.9 million for the three months ended June 30, for a bottom-line loss of -46.5% sales growth of 6.2% compared with Q2 2019. Earnings per share […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Organogenesis Inc.

Organogenesis boosts outlook on higher Q2 sales

August 9, 2019 By Nancy Crotti

Organogenesis (NSDQ:ORGO) beat The Street on sales for the second quarter of 2019 and boosted its outlook for the rest of the year amid continued strong sales growth in its wound-care business. The Canton, Mass.–based regenerative medicine company reported a loss of $9.65 million, or -11¢ per share, on sales of $64.95 million for the […]

Filed Under: Blog, Business/Financial News, Featured, MassDevice Earnings Roundup, Wound Care Tagged With: Organogenesis Inc.

Organogenesis boosts revenue, cuts losses in Q1

May 10, 2019 By Nancy Crotti

Organogenesis (NSDQ:ORGO) posted a smaller loss year-over-year during its first quarter, and boosted its outlook for the rest of the year amid strong sales growth in its wound-care business. The Canton, Mass.–based regenerative medicine company reported a loss of $15.7 million, or 17 cents per share, on sales of $57.1 million for the three months […]

Filed Under: Business/Financial News, Wall Street Beat, Wound Care Tagged With: Organogenesis Inc.

Appeals court reverses Organogenesis win in gender bias, retaliation lawsuit

March 21, 2019 By Fink Densford

A U.S. federal appeals court this week reversed a win for Organogenesis in an employment discrimination and retaliation lawsuit from former employees, according to recently released court documents. The U.S Court of Appeals for the Ninth Circuit reversed and remanded the case filed by former employees Angela Gonzales, Linda Boyd and Brandee Colombo against Canton, […]

Filed Under: Featured, Legal News Tagged With: Organogenesis Inc.

Shareholders approve Avista, Organogenesis tie up

December 11, 2018 By Fink Densford

Private equity firm Avista Healthcare Public Acquisition Corp. yesterday approved its merger with regenerative medicine company Organogenesis. The merger won approval yesterday at separate special meetings of shareholders for both companies, Canton, Mass.-based Organogenesis said. As part of the deal, Avista invested a total of $92 million in the combined company, Organogenesis said. Avista also […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Regenerative Medicine Tagged With: Avista Capital, Organogenesis Inc.

Avista to acquire Organogenesis

August 20, 2018 By Fink Densford

Avista Healthcare Public Acquisition group said last Friday it inked deal to acquire Organogenesis for an undisclosed amount. As part of the deal, Avista Capital Partners private equity firm will invest $92 million into the newly acquired company, which is slated to be listed on the Nasdaq under the ticker symbol “ORGO” following the closing […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Regenerative Medicine, Wound Care Tagged With: Organogenesis Inc.

Organogenesis launches new sizing option for PuraPly wound care device

March 15, 2018 By Sarah Faulkner

MIT-spinoff Organogenesis announced today that its PuraPly antimicrobial wound care device is now available in a 1.6-cm disc size. The Canton, Mass.-based company’s PuraPly AM product includes a broad-spectrum antibiotic, polyhexamethylene biguanide, embedded into a purified native collagen matrix. The device is cleared to treat an array of wound types, including pressure ulcers, surgical wounds, trauma wounds and […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Wound Care Tagged With: Organogenesis Inc.

RTI Surgical taps director for CFO, fills out roster | Personnel Moves, Sept. 19, 2017

September 19, 2017 By Brad Perriello

RTI Surgical (NSDQ:RTIX) said yesterday that it’s tapping a board member to be CFO and adding a pair of medical device veterans to its executive roster. Alachua, Fla.-based RTI said it named director Jonathon Singer as its finance & administration chief effective Oct. 2, replacing Robert Jordheim. Singer, who resigned his board seat to accept […]

Filed Under: Business/Financial News Tagged With: 3B Medical, Bonesupport, Haemonetics, Obalon Therapeutics, Organogenesis Inc., orthosalespartners, Personnel Moves, rationalsurgicalsolutions, RTI Surgical, silktherapeutics, Titan Spine

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy